This is an early access version
,
Department of Surgery, Faculty of Medicine, University of North Sumatra , Medan , Indonesia
,
Department of Surgery, Faculty of Medicine, University of North Sumatra , Medan , Indonesia
Department of Surgery, Faculty of Medicine, University of North Sumatra , Medan , Indonesia
Department of Surgery, Faculty of Medicine, University of North Sumatra , Medan , Indonesia
Faculty of Mediicne, University of North Sumatra , Medan , Indonesia
Department of Surgery, Faculty of Medicine, University of North Sumatra , Medan , Indonesia
Aim To determine whether Ki67 can be predicted through its correlation with the estrogen receptor (ER) and progesterone receptor (PR), to identify breast cancer subtypes and evaluate cell proliferation level and prognosis.
Methods Patient clinical data were collected from medical records and pathology laboratory reports at Teaching Hospital, Faculty of Medicine, Universitas Sumatera Utara. Ki67 expression, as a proliferation marker, was measured and detected using immunohistochemistry (IHC). Ki67 data were categorized into two groups: <20% (low proliferation) and >20% (high proliferation). Statistical analysis was conducted by calculating the frequency distribution and percentage of receptor status and using the χ2 test.
Results The study revealed an inverse relationship between ER/PR status and Ki67 (<0.001). Low Ki67 levels were generally associated with positive ER/PR status, while high Ki67 levels showed increased frequency in ER/PR- negative cases.
Conclusion: Ki67 expression can be determined based on the frequency of ER/PR status; however, these markers have distinct roles in the management of breast cancer patients.
Conceptualization, D.H. and E.T.P.; Data curation, D.H., M.A.A., K.H.C., M.B. and E.T.P.; Formal Analysis, D.H., K.H.C. and M.B.; Funding acquisition, D.H. and E.T.P.; Investigation, D.H. and M.A.A.; Project administration, D.H.; Resources, D.H. and E.T.P.; Supervision, D.H., K.S.A. and E.T.P.; Validation, D.H. and K.S.A.; Visualization, D.H. and E.T.P.; Writing – original draft, D.H. and M.A.A.; Writing – review & editing, D.H., M.A.A., K.H.C., M.B., K.S.A. and E.T.P.; Methodology, M.A.A., K.H.C., M.B. and E.T.P.; Software, M.A.A. All authors have read and agreed to the published version of the manuscript.
None
Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. 
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.